amyloidosis in 592 patients with mass spectrometry-verified typing
Published 5 years ago • 237 plays • Length 5:00Download video MP4
Download video MP3
Similar videos
-
6:19
amyloid typing by mass spectrometry in clinical practice
-
3:57
accurate subtyping of amyloidosis
-
5:07
the clinical impact of proteomics in amyloid typing
-
1:51
the role of mass spectrometry in response assessment in patients with al amyloidosis
-
0:59
mcp 60 seconds with dr eli muchtar on light chain amyloidosis
-
5:24
wild-type transthyretin cardiac amyloidosis
-
3:15
goal of therapy in al amyloidosis: what predicts the best outcome?
-
1:58
identifying the proteome to diagnose amyloidosis subsets
-
4:47
blood mass-spectrometry for detecting disease progression
-
5:40
immunoglobulin light chain amyloidosis consensus statement
-
59:50
pathology of amyloidosis - insights from proteomics
-
1:07
mcp 60 seconds with dr ian chang on light chain amyloidosis
-
2:56
early vs. deferred transplantation in al amyloidosis
-
5:54
immunoglobulin light chain amyloidosis-associated myopathy
-
1:34
the importance of identifying ah amyloidosis in patients with normal free light chain levels
-
9:50
treatment update: medications for cardiac amyloidosis
-
5:23
dual antibody therapy in patients with systemic al amyloidosis and cardiac involvement
-
4:45
treatment of al amyloidosis: (msmart) consensus statement 2020